Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 1426

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7A
Chunk 1426
---
5. She also received her M.B.A. from Cornell University in 2002, where she was a Park
Leadership Fellow, and her J.D. from George Mason University in 2005, and is currently a licensed attorney in the State of New
York. She was selected to serve on our board of directors due to her experience serving on the boards of directors of public companies. 

Family
Relationships

There
are no family relationships among any of our directors or executive officers.

Involvement
in Certain Legal Proceedings 

None.

Code
of Ethics 

We
have a written code of conduct and ethics that applies to our directors, officers, employees and contractors, including our principal
executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions.
The code of conduct and ethics is available on our website at www.channeltherapeutics.com. We intend to disclose
future amendments to such code, or any waivers of its requirements, applicable to any principal executive officer, principal financial
officer, principal accounting officer or controller, or persons performing similar functions or our directors on our website identified
above or in a Current Report on Form 8-K that we would file with the SEC.

Delinquent
Section 16(a) Reports 

Under
the securities laws of the United States, our directors, executive (and certain other) officers, and any persons holding ten percent
or more of our Common Stock must report on their ownership of the Common Stock and any changes in that ownership to the SEC. Specific
due dates for these reports have been established. During the fiscal year ended December 31, 2024, all reports required to be
filed by such persons pursuant to Section 16(a) were filed on a timely basis.

84 

Corporate
Governance 

Board
of Directors

Our
board of directors consists of four members. The primary responsibilities of our board of directors are to provide oversight,
strategic guidance, counseling and direction to our management. Our board of directors meets on a regular basis and additionally
as required.

Director
Independence

Applicable
NYSE American rules require a majority of a listed company’s board of directors to be comprised of independent directors
within one year of listing. In addition, NYSE American rules require that, subject to specified exceptions, each member of a listed
company’s audit, compensation and nominating and corporate governance committees be independent and that audit committee
members also satisfy independence criteria set forth in Rule 10